共 58 条
Synthesis and crystallographic characterization of multi-donor N-heterocyclic carbene chelating ligands and their silver complexes:: Potential use in pharmaceuticals
被引:76
作者:
Garrison, JC
[1
]
Tessier, CA
[1
]
Youngs, WJ
[1
]
机构:
[1] Univ Akron, Dept Chem, Akron, OH 44325 USA
基金:
美国国家科学基金会;
美国国家卫生研究院;
关键词:
silver N-heterocyclic carbenes;
pharmaceuticals;
imidazolium salts;
mixed donor ligands;
X-ray;
trinuclear silver cluster;
D O I:
10.1016/j.jorganchem.2005.07.102
中图分类号:
O61 [无机化学];
学科分类号:
070301 ;
081704 ;
摘要:
The potential for N-heterocyclic carbenes (NHCs) to be used as novel chelating ligands for bio-inorganic pharmaceuticals is discussed. In this paper, we design, synthesize and characterize two NHC precursors, 6 and 7, that we believe have potential for use as metal chelators for pharmaceuticals. The NHC precursors are composed of imidazolium and pyridine rings that would form mixed donor NHCs upon metallation with medicinally relevant metals. The exploration of the silver chemistry of 6 yielded the dimeric silver NHC complex 8[BPh4](2). The study of the silver chemistry of 7 gave 9[1/3(Ag4Br7)] and 10[NO3](3). Complex 9[1/3(Ag4Br7)] appears to be a silver biscarbene charge balanced by a silver bromide anionic cluster. Complex 10[NO3](3) is a trinuclear silver cluster that is stabilized by NHCs and pyridine rings. Silver NHCs have shown themselves to be excellent transmetallation agents for access to other metal NHC systems. It is envisioned that the silver NHCs 8[BPh4](2), 9[1/3(Ag4Br7)] and 10[NO3](3) will readily transfer to medicinally relevant metals, such Rh-105. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:6008 / 6020
页数:13
相关论文